PSUSA/00000662/202503

Herbal medicinal product: Oenotherae oleum, Oenothera biennis L.; Oenothera lamarckiana L., C: ongoing call for scientific data

Herbal medicinal product: Cimicifugae rhizoma, Cimicifuga racemosa (L.) Nutt., C: ongoing call for scientific data

Human medicines European public assessment report (EPAR): Imjudo, tremelimumab, Date of authorisation: 20/02/2023, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Steglatro, ertugliflozin, Date of authorisation: 21/03/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Sephience, sepiapterin, Date of authorisation: 19/06/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Romvimza, vimseltinib, Date of authorisation: 17/09/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Qinlock, ripretinib, Date of authorisation: 18/11/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Lumark, lutetium (177Lu) chloride, Date of authorisation: 18/06/2015, Revision: 9, Status: Withdrawn

Human medicines European public assessment report (EPAR): HyQvia, human normal immunoglobulin, Date of authorisation: 16/05/2013, Revision: 25, Status: Authorised